Risk factors, incidence, and morbidity associated with antibiotic-associated diarrhea in intensive care unit patients receiving antibiotic monotherapy

Table 3 Antibiotic monotherapy and antibiotic-associated diarrhea, n (%)

Variables	AAD	No AAD	P value
No. of patients	45	164
Beta-lactam plus enzyme inhibitors	33 (73.34)	92 (56.10)	0.037
Carbapenems	7 (15.56)	32 (19.51)	0.564
Cephalosporins	1 (2.22)	22 (13.41)	0.063
Quinolones	2 (4.44)	10 (6.10)	0.952
Antifungals	2 (4.44)	2 (1.22)	0.433
Glycopeptides	0 (0.00)	2 (1.22)	-
Oxazolidinones	0 (0.00)	4 (2.44)	-

The Beta-lactam plus enzyme inhibitor antibiotics were piperacillin-tazobactam and cefoperazone-sulbactam. AAD: Antibiotic-associated diarrhea.